Review

The role of glycation in the pathogenesis of diabetic polyneuropathy

R H M King

Department of Clinical Neurosciences, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK

Correspondence to:
Dr King rking{at}rfc.ucl.ac.uk

The most common neuropathy associated with diabetes mellitus is a distal sensory polyneuropathy. The relative importance of the direct effects of prolonged glycaemia on nervous tissue compared with indirect damage resulting from changes in blood vessels is not known. Although the importance of glycaemia is confirmed by a study showing that the incidence of neuropathy is greatly reduced by strict glycaemic control, many of the details of the deleterious effects of glycaemia on the peripheral nervous system (PNS) are not understood. These may be the result of direct damage to any of the cells in the PNS or the disruption of neuronal metabolism, axonal transport mechanisms, or repair capabilities; in addition, they may result from the effects of glycation on PNS connective tissue or a combination of some or all of the above mentioned mechanisms. The relative importance of these various mechanisms by which diabetes damages the PNS is a matter of conjecture. Therapeutic approaches targeting a specific mechanism such as those utilising aldose reductase inhibitors, or advanced glycation endproduct inhibitors have met with limited success. Clearly, it is difficult to design a treatment for diabetic neuropathy while its pathogenesis is still poorly understood.

Key Words: diabetes mellitus • glycation • peripheral nerve

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Del Carro, U., Fiorina, P., Amadio, S., De Toni Franceschini, L., Petrelli, A., Menini, S., Boneschi, F. M., Ferrari, S., Pugliese, G., Maffi, P., Comi, G., Secchi, A. (2007). Evaluation of Polyneuropathy Markers in Type 1 Diabetic Kidney Transplant Patients and Effects of Islet Transplantation: Neurophysiological and skin biopsy longitudinal analysis. Diabetes Care 30: 3063-3069 [Abstract] [Full Text]  
• Vincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., Feldman, E. L. (2007). Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress. Endocrinology 148: 548-558 [Abstract] [Full Text]  
• Jaleel, A., Halvatsiotis, P., Williamson, B., Juhasz, P., Martin, S., Nair, K. S. (2005). Identification of Amadori-Modified Plasma Proteins in Type 2 Diabetes and the Effect of Short-Term Intensive Insulin Treatment. Diabetes Care 28: 645-652 [Abstract] [Full Text]  
• Boulton, A. J.M., Malik, R. A., Arezzo, J. C., Sosenko, J. M. (2004). Diabetic Somatic Neuropathies. Diabetes Care 27: 1458-1486 [Full Text]  
• Singleton, J. R., Smith, A. G., Russell, J. W., Feldman, E. L. (2003). Microvascular Complications of Impaired Glucose Tolerance. Diabetes 52: 2867-2873 [Abstract] [Full Text]  
• Malik, R. (2003). Failure to define the pathogenesis and treatment of human diabetic neuropathy. British Journal of Diabetes & Vascular Disease 3: 107-111 [Abstract]